v3.26.1
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Ordinary Shares
Common Class A
Private placement
Ordinary Shares
Common Class A
Ordinary Shares
Common Class B
Additional Paid-in Capital
Private placement
Additional Paid-in Capital
Accumulated Deficit
Private placement
Total
Balance at the beginning at Dec. 31, 2025     $ 431   $ 24,569 $ (59,143)   $ (34,143)
Balance at the beginning (in shares) at Dec. 31, 2025 [1]     4,312,500          
Sale of 529,000 Private Placement Units $ 53     $ 5,289,947     $ 5,290,000  
Sale of 529,000 Private Placement Units (in shares) 529,000              
Fair value of Public Warrants at issuance         2,632,000     2,632,000
Allocated value of transaction costs to public warrants         (192,355)     (192,355)
Share-based compensation to director nominees         1,451,125     1,451,125
Change on over-allotment liability         200     200
Accretion for Class A ordinary shares to redemption amount         (9,205,486) (4,260,672)   (13,466,158)
Net income (loss)           (1,043,819)   (1,043,819)
Balance at the end at Mar. 31, 2026   $ 53 $ 431     (5,363,634)   (5,363,150)
Balance at the end (in shares) at Mar. 31, 2026   529,000 4,312,500 [1]          
Balance at the beginning at Dec. 31, 2025     $ 431   24,569 (59,143)   (34,143)
Balance at the beginning (in shares) at Dec. 31, 2025 [1]     4,312,500          
Change on over-allotment liability               49,800
Net income (loss)               207,058
Balance at the end at Jun. 30, 2026   $ 53 $ 411     (5,529,401)   (5,528,937)
Balance at the end (in shares) at Jun. 30, 2026   529,000 4,112,500 [1]          
Balance at the beginning at Mar. 31, 2026   $ 53 $ 431     (5,363,634)   (5,363,150)
Balance at the beginning (in shares) at Mar. 31, 2026   529,000 4,312,500 [1]          
Change on over-allotment liability               50,000
Accretion for Class A ordinary shares to redemption amount         (44,251) (1,416,644)   (1,460,895)
Forfeiture of Founder Shares     $ (20)   20      
Forfeiture of Founder Shares (in shares) [1]     (200,000)          
Capital contribution         $ 44,231     44,231
Net income (loss)           1,250,877   1,250,877
Balance at the end at Jun. 30, 2026   $ 53 $ 411     $ (5,529,401)   $ (5,528,937)
Balance at the end (in shares) at Jun. 30, 2026   529,000 4,112,500 [1]          
[1] Includes 200,000 Class B ordinary shares, $0.0001 par value, subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). On February 25, 2026, the Company consummated the closing of an additional 1,450,000 Units in connection with a partial exercise of the underwriters’ over-allotment option, generating gross proceeds of $14,500,000 (see Note 1). On April 4, 2026, the remaining 200,000 Class B ordinary shares were surrendered pursuant to the expiration of the underwriters’ over-allotment option for no consideration.